Amag Pharmaceuticals Inc. said the company would divest two of women’s health products, after the drugmaker conducted a strategic review under pressure from hedge fund Caligan Partners.
https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png00Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2020-01-09 07:17:222020-01-09 07:17:22Amag Pharmaceuticals to divest two women's health drugs, CEO to step down
